Hualan Biological Engineering Inc. researches, develops, produces, and commercializes blood products, vaccines, and genetic engineering products in China and internationally. The company offers human serum albumin to treat blood loss trauma, shock caused by burns, intracranial pressure and persistent, liver cirrhosis, and kidney disease; edema for hypoproteinemia, neonatal hyperbilirubinemia, cardiopulmonary bypass, adjuvant treatment of burns, hemodialysis, and human respiratory distress syndrome; intravenous human immunoglobulin (pH4) for immunoglobulin deficiency and autoimmune diseases; and human immunoglobulin to prevent measles and infectious hepatitis. It also provides hepatitis b human immunoglobulin to prevent hepatitis; immunoglobulin for rabies patients; human tetanus immune globulin for tetanus; human coagulation factor blood for bleeding symptoms; human prothrombin complex for congenital and acquired coagulation factor II, VH, IX, X deficiency, overdose of anticoagulants, vitamin k deficiency, bleeding, and hemophilia; and human fibrinogen for congenital fibrinogen reduction, and liver damage and cirrhosis, disseminated intravascular coagulation, postpartum hemorrhage, and coagulation disorders.